Dr. Serge Lyashchenko, PharmD

Dr. Lyashchenko is a faculty member of Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College. He oversees the Radiochemistry and Molecular Imaging Probe Core at MSKCC and has translated 50+ agents into radiopharmaceutical development. He co-founded Evergreen Theragnostics and serves as an advisor to the IAEA and WHO regarding global radiopharmaceutical access.